SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHardide Regulatory News (HDD)

Share Price Information for Hardide (HDD)

Share Price is delayed by 15 minutes
Get Live Data
60.00    0.50 (0.84%)
Bid:
59.00
Ask:
61.00
Spread: 2.00 (3.39%)
Market Cap: £47.29m
HDD Live PriceLast checked at - London Stock Exchange

Intraday Hardide Share Chart

Board Changes

3 Dec 2024 07:00

RNS Number : 5000O
Hardide PLC
03 December 2024
 

The information contained within this announcement is deemed by Hardide to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended. 

 

3 December 2024

 

Hardide plc

("Hardide", "the Group" or "the Company")

 

Appointment of Dr. Bryan Allcock as an Independent Non-Executive Director

 

Hardide plc, the provider of advanced surface treatment solutions, is pleased to announce the appointment of Dr. Bryan Allcock to the Board today as an Independent Non-Executive Director. Bryan will succeed Tim Rice as Hardide's Senior Independent Director and Chair of the Remuneration Committee with effect from 1 January 2025, as Tim will be stepping down from the Board on 31 December 2024.

 

Bryan has career long experience working in the advanced materials, surface engineering and coatings industry.

 

He is currently CEO of his own business, TRL9 Limited, which runs a portfolio of research, development and deployment projects, including the use of high entropy alloys. Bryan acts as a subject matter expert to the Ministry of Defence and BAE Systems for the coating of flight decks for Queen Elizabeth Class aircraft carriers and has collaborative research contracts with Jaguar Land Rover, the Defence and Security Accelerator (DASA) and the European Space Agency.

 

Bryan was formerly Global CEO for the Services business of Castolin Eutectic Limited, part of the Messer Group, where he ran an international £56m revenue business delivering surface engineering and advanced coating solutions. Bryan joined Castolin Eutectic having sold his own business, Monitor Coatings, to them in 2013.

 

Bryan spent his earlier career as Head of Technical Services at Flight Refuelling Limited, part of Cobham plc, where he grew profits significantly through business development of the coatings division, operational improvement and efficiency initiatives.

 

Bryan holds an MBA, has a degree in applied chemistry and materials, and holds a PhD in Corrosion Engineering from Cranfield University. He is a fellow of the Institute of Materials, Minerals and Mining and has been a strategic advisor to the Institute.

 

Further information regarding Bryan Allcock, as required by Schedule 2(g) of the AIM Rules for Companies, is set out below.

 

Andrew Magson, Non-Executive Chair, commented:

 

"We are delighted that Bryan is joining the Hardide Board. He has a deep understanding of the coatings and surface treatment sectors and a rare combination of technical, business development, sales and marketing skills. Together with an entrepreneurial mind-set, this means his knowledge and experience is highly aligned with Hardide's strategy of better commercialising the business and accelerating revenue growth.

 

I'd also like to place on record the Board's thanks to Tim Rice, who has provided wise counsel to all of us during his six years of service as our Senior Independent Director. Tim was instrumental to Hardide's success in developing its business with the aerospace sector. We wish him well for the future."

 

 

Dr. Bryan Allcock BSc (Hons) PhD, MBA, FIMMM (Age 57)

 

Current Directorships:

 

TRL9 Limited

Solar Fluidics UK Limited

Burgham Park Residents Association Limited

Zonne Limited

UVCR Limited

 

Past Directorships in the last 5 years:

 

None.

 

Bryan Allcock does not own any ordinary shares or options over ordinary shares in the Company.

 

There is no further information on Bryan Allcock required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

 

 

For further information:

Hardide plc

Andrew Magson (Non-Executive Chair)

Tim Rice (Senior Independent Director)

Matt Hamblin (CEO)

 

Tel: +44 (0) 1869 353 830

 

 

 

Cavendish Capital Markets Ltd - Nominated Adviser and Broker

Henrik Persson/ Abigail Kelly / Elysia Bough (Corporate Finance)

Jasper Berry / Dale Bellis (Sales)

 

Tel: +44 (0) 2072 200 500

 

Notes to editors:

www.hardide.com

 

Hardide develops, manufactures and applies advanced technology tungsten carbide/tungsten metal matrix coatings to a wide range of engineering components. Its patented technology is unique in combining in one material, a mix of toughness and resistance to abrasion, erosion and corrosion; together with the ability to coat accurately interior surfaces and complex geometries. The material is proven to offer dramatic improvements in component life, particularly when applied to components that operate in very aggressive environments. This results in cost savings through reduced downtime and increased operational efficiency as well as a reduced carbon footprint. Customers include leading companies operating in the energy sectors, valve and pump manufacturing, industrial gas turbine, precision engineering and aerospace industries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFITFSLFIIS
Date   Source Headline
18th May 20217:00 amRNSInterim Results
28th Apr 20213:16 pmRNSHolding(s) in Company
19th Mar 20213:19 pmRNSHolding(s) in Company
15th Mar 202112:06 pmRNSResult of AGM
15th Mar 20217:00 amRNSAGM Statement
25th Feb 202110:22 amRNSIssue of Options
19th Feb 20215:01 pmRNSHolding(s) in Company
19th Feb 20217:00 amRNSNotice of AGM
5th Feb 20217:00 amRNSHolding(s) in Company
1st Feb 202110:50 amRNSResult of Fundraising
1st Feb 20217:00 amRNSProposed equity fundraising and CBILS loan
7th Dec 20207:00 amRNSPreliminary results for year ended 30 Sept 2020
23rd Sep 20207:00 amRNSPre-close Trading Update
3rd Aug 20205:24 pmRNSDirector Dealing - Correction
3rd Aug 202012:17 pmRNSDirector Dealing
23rd Jul 20207:00 amRNSResignation of Non-Executive Director
16th Jul 20207:00 amRNSTrading Update
25th Jun 20202:30 pmRNSExercise of Options
23rd Jun 20202:14 pmRNSHolding(s) in Company
17th Jun 20203:43 pmRNSChange of Registered Office
20th May 20204:37 pmRNSIssue of Options
19th May 20207:00 amRNSInterim Results
21st Apr 20207:00 amRNSQueen’s Award for Enterprise
14th Apr 20205:00 pmRNSExercise of Options
31st Mar 20207:00 amRNSTRADING UPDATE AND THE IMPACT OF COVID-19
17th Feb 202012:47 pmRNSResult of AGM
17th Feb 20207:00 amRNSAGM Statement
10th Feb 20207:00 amRNSPresenting at The Growth & Innovation Forum
27th Jan 20202:43 pmRNSHolding(s) in Company
27th Jan 20207:00 amRNSAppointment of Finance Director
21st Jan 20208:15 amRNSDirector/PDMR Shareholding
21st Jan 20207:00 amRNSPlacing to raise £2.5 million
16th Dec 20195:22 pmRNSGrant of Options
9th Dec 20197:00 amRNSPreliminary Results
13th Nov 20197:00 amRNSHardide approved for F-35 Joint Strike Fighter
11th Nov 20197:00 amRNSPatent Award
15th Oct 20198:23 amRNSHolding(s) in Company
26th Sep 20197:00 amRNSTrading Update
23rd Aug 20197:00 amRNSAppointment of Joint Broker
21st Aug 20197:00 amRNSOrders for three new coating reactors
12th Aug 20198:17 amRNSHardide selected for Airbus A330 wing components
8th Jul 20197:00 amRNSContract Award
28th Jun 20197:00 amRNSExercise of Options and Director Shareholdings
11th Jun 20195:00 pmRNSHolding(s) in Company
14th May 20197:00 amRNSInterim Results
14th May 20197:00 amRNSHardide selected for Airbus A380 wing components
13th Mar 20197:00 amRNSHardide Coating Extends Life of Turbine Blades
7th Mar 201911:37 amRNSHolding(s) in Company
7th Mar 201911:36 amRNSHolding(s) in Company
4th Mar 20193:16 pmRNSResult of AGM and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.